Factors | IHD | Cardiac mortality | ||||||||
N studies | Events/participants | RR (95% CI) | I 2 | P valuea | N studies | Events/participants | RR (95% CI) | I 2 | P valuea | |
Degrees of hypothyroidism | ||||||||||
 All hypothyroidism | 4 | 13,444/593,499 | 1.13 (1.04–1.23) | 0.0% | Reference | 2 | 282/2836 | 1.83 (0.72–4.62) | 90.0% | 0.75 |
 SCH | 8 | 3400/21,623 | 1.12 (0.89–1.42) | 55.8% | 0.74 | 5 | 819/32,086 | 2.00 (1.34–2.97) | 47.8% | Reference |
 OHypo | 1 | 18/474 | 2.54 (0.87–7.41) | - | 0.30 | - | - | - | - | - |
Study population | ||||||||||
 Convenience sample | 4 | 1406/8946 | 1.08 (0.66–1.79) | 58.2% | 0.73 | 5 | 398/6595 | 2.33 (1.39–3.91) | 70.7% | Reference |
  Cardiac patientsb | 3 | 1277/8149 | 1.15 (0.68–1.94) | 67.7% | - | 4 | 393/5596 | 2.22 (1.28–3.83) | 76.5% | - |
 Population-based | 9 | 15,456/606,650 | 1.12 (1.00–1.25) | 36.8% | Reference | 2 | 703/28,327 | 1.43 (1.10–1.86) | 0.0% | 0.33 |
Mean age | ||||||||||
 ≥80 years | - | - | - | - |  | - | - | - | - | - |
 65–79 years | 8 | 3417/20,298 | 1.06 (0.89–1.27) | 37.4% | 0.45 | 2 | 236/3077 | 1.91 (0.61–5.93) | 82.3% | 0.68 |
 <65 years | 5 | 13,445/595,298 | 1.19 (1.02–1.39) | 51.0% | Reference | 5 | 865/31,845 | 2.07 (1.39–3.07) | 61.8% | Reference |
Location | ||||||||||
 Europe | 7 | 13,907/600,542 | 1.10 (0.95–1.26) | 31.7% | 0.23 | 4 | 814/31,087 | 1.91 (1.28–2.86) | 52.8% | 0.26 |
 North America | 4 | 2675/12,727 | 1.08 (0.95–1.24) | 15.2% | 0.22 | 1 | 205/2430 | 1.14 (0.76–1.71) | - | Reference |
 Asia | 1 | 18/474 | 2.54 (0.87–7.41) | - | Reference | 2 | 82/1405 | 3.02 (2.00–4.56) | 0.0% | 0.10 |
 Oceania | 1 | 262/1853 | 1.80 (1.20–2.70) | - | 0.63 | - | - | - | - | - |
Female proportion | ||||||||||
 ≥50% | 9 | 15,773/610,042 | 1.07 (0.98–1.18) | 19.9% | 0.08 | 3 | 708/29,326 | 1.47 (1.12–1.94) | 2.3% | Reference |
 <50% | 4 | 1089/5554 | 1.47 (1.04–2.07) | 40.9% | Reference | 4 | 393/5596 | 2.22 (1.28–3.83) | 76.5% | 0.52 |
Mean follow-up | ||||||||||
 ≥10 years | 5 | 3615/45,383 | 1.18 (0.98–1.42) | 55.4% | Reference | 3 | 708/29,326 | 1.47 (1.12–1.94) | 2.3% | Reference |
 5–10 years | 2 | 11,491/557,482 | 1.13 (1.02–1.25) | 0.0% | 0.73 | - | - | - | - | - |
 <5 years | 6 | 1756/12731 | 1.07 (0.75–1.53) | 53.9% | 0.59 | 4 | 393/5596 | 2.22 (1.28–3.83) | 76.5% | 0.52 |
Factors | Cardiovascular mortality | All-cause mortality | ||||||||
N studies | Events/participants | RR (95% CI) | I 2 | P valuea | N studies | Events/participants | RR (95% CI) | I 2 | P valuea | |
Degrees of hypothyroidism | ||||||||||
 All hypothyroidism | 5 | 2724/20,707 | 0.99 (0.70–1.39) | 42.0% | 0.35 | 21 | 98,621c/876,811 | 1.21 (1.07–1.37) | 87.6% | 0.51 |
 SCH | 12 | 2549/137,310 | 1.15 (1.00–1.32) | 0.0% | Reference | 18 | 13,529/159,104 | 1.32 (1.13–1.54) | 65.9% | Reference |
 OHypo | - | - | - | - | - | 1 | 6/474 | 1.78 (0.21–14.98) | - | 0.80 |
Study population | ||||||||||
 Convenience sample | 5 | 1454/12,229 | 1.15 (0.95–1.39) | 0.0% | 0.70 | 20 | 9004c/54,577 | 1.45 (1.27–1.66) | 63.4% | 0.009 |
  Cardiac patientsb | 2 | 1333/9820 | 1.10 (0.83–1.45) | 0.0% | - | 13 | 4643c/38,219 | 1.51 (1.26–1.81) | 65.7% | - |
 Population-based | 12 | 3819/145,788 | 1.08 (0.86–1.36) | 33.3% | Reference | 20 | 103,152/981,812 | 1.10 (0.95–1.28) | 91.7% | Reference |
Mean age | ||||||||||
 ≥80 years | 1 | 87/539 | 0.55 (0.33–0.93) | - | 0.004 | 3 | 6216/18,267 | 1.05 (0.55–1.98) | 95.2% | Reference |
 65–79 years | 11 | 2799/22,989 | 1.08 (0.94–1.23) | 0.0% | 0.04 | 20 | 9706/49,057 | 1.15 (1.03–1.29) | 34.7% | 0.73 |
 <65 years | 5 | 2387/134,489 | 1.53 (1.16–2.01) | 0.0% | Reference | 17 | 96,234c/969,065 | 1.38 (1.19–1.60) | 89.3% | 0.22 |
Location | ||||||||||
 Europe | 7 | 1807/13,446 | 0.96 (0.74–1.23) | 33.4% | 0.045 | 19 | 92,477/847,659 | 1.09 (0.95–1.26) | 83.2% | 0.92 |
 North America | 5 | 2544/24,417 | 1.08 (0.90–1.29) | 0.0% | 0.097 | 10 | 8176c/40,891 | 1.26 (1.12–1.41) | 54.5% | 0.50 |
 Asia | 4 | 731/118,301 | 1.72 (1.13–2.62) | 0.0% | Reference | 10 | 10,671/143,981 | 1.75 (1.42–2.15) | 60.1% | 0.07 |
 Oceania | 1 | 191/1853 | 1.50 (0.90–2.50) | - | 0.70 | 1 | 832/3858 | 1.06 (0.86–1.31) | - | Reference |
Female proportion | ||||||||||
 ≥50% | 12 | 3814/149,254 | 1.06 (0.87–1.29) | 29.5% | Reference | 22 | 103,550/990,510 | 1.13 (0.97–1.31) | 91.1% | Reference |
 <50% | 5 | 1459/8763 | 1.23 (0.96–1.58) | 0.0% | 0.35 | 18 | 8606c/45,879 | 1.42 (1.25–1.63) | 65.8% | 0.03 |
Mean follow-up | ||||||||||
 ≥10 years | 7 | 3338/139,867 | 1.21 (0.98–1.50) | 16.2% | 0.12 | 9 | 14,896/165,332 | 1.25 (0.98–1.59) | 89.7% | 0.44 |
 5–10 years | 5 | 399/4517 | 1.19 (0.94–1.52) | 0.0% | 0.20 | 13 | 88,149c/822,913 | 1.10 (0.92–1.32) | 85.8% | Reference |
 <5 years | 5 | 1536/13,633 | 0.88 (0.63–1.23) | 34.0% | Reference | 18 | 9111c/48,144 | 1.37 (1.19–1.58) | 72.7% | 0.09 |